GGrantIndex
← Leaderboards

Santosh Saraf

University Of Illinois At Chicago

$5,561,155
Attributed
$9,306,710
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY201525
$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,306,710 · 7

By mechanism

R01$8,309,258 · 4
K23$700,333 · 1
R03$159,900 · 1
K24$137,219 · 1

Top collaborators

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Hemolysis

Research focus

HemolysisSickle Cell AnemiaAdultHemoglobinKidney DiseasesMorbidity - Disease RateVariantMortalityKidneyAffectPreventUrineFunctional DisorderSickle CellHigh RiskRenal FunctionChronic Kidney FailurePathway InteractionsRenal DamageFutureRisk FactorsOrganOxidative StressPredisposition

Grant awards (21)

Clonal hematopoiesis and inherited genetic variation in sickle cell disease$779,601
R01 · FY2025 · HL
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using SGLT2 Inhibitors$755,853
R01 · FY2025 · HL · contact PI
Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)$610,088
R01 · FY2025 · HL
Mentoring & Patient-Oriented Research in Sickle Cell-Related Kidney Disease$137,219
K24 · FY2025 · HL · contact PI
Clonal hematopoiesis and inherited genetic variation in sickle cell disease$764,009
R01 · FY2024 · HL
Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)$606,572
R01 · FY2024 · HL
Pathways of Cell-Free Hemoglobin in Sickle Cell Nephropathy$399,750
R01 · FY2024 · HL · contact PI
Clonal hematopoiesis and inherited genetic variation in sickle cell disease$817,595
R01 · FY2023 · HL
Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)$626,209
R01 · FY2023 · HL
Pathways of Cell-Free Hemoglobin in Sickle Cell Nephropathy$399,750
R01 · FY2023 · HL · contact PI
Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)$645,294
R01 · FY2022 · HL
Pathways of Cell-Free Hemoglobin in Sickle Cell Nephropathy$399,750
R01 · FY2022 · HL · contact PI
Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)$705,287
R01 · FY2021 · HL
Pathways of Cell-Free Hemoglobin in Sickle Cell Nephropathy$399,750
R01 · FY2021 · HL · contact PI
Pathways of Cell-Free Hemoglobin in Sickle Cell Nephropathy$399,750
R01 · FY2020 · HL · contact PI
Cell-free Hemoglobin in Sickle Cell Acute Kidney Injury$79,950
R03 · FY2020 · HL · contact PI
Cell-free Hemoglobin in Sickle Cell Acute Kidney Injury$79,950
R03 · FY2019 · HL · contact PI
Genetics and Genomics of Sickle Cell Nephropathy.$185,152
K23 · FY2018 · HL · contact PI
Genetics and Genomics of Sickle Cell Nephropathy.$185,152
K23 · FY2017 · HL · contact PI
Genetics and Genomics of Sickle Cell Nephropathy.$185,152
K23 · FY2016 · HL · contact PI
Genetics and Genomics of Sickle Cell Nephropathy.$144,877
K23 · FY2015 · HL · contact PI